Review

COVID-19 Vaccine Development, Trials and Tribulations

Juny Sebastian1, Mandyam Dhati Ravi2, Tegginamat Pramod Kumar3★★ Corresponding author

  1. 1Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, S S Nagara, Mysuru, Karnataka, INDIA.
  2. 2Department of Pediatrics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, S S Nagara, Mysuru, INDIA.
  3. 3Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, S S Nagara, Mysuru, Karnataka, INDIA.

CORRESPONDENCE

Tegginamat Pramod Kumar

Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, S S Nagara, Mysuru, Karnataka, INDIA.

pramodkumar@jssuni.edu.in

Received: 16-04-2020; Revised: 28-05-2020; Accepted: 02-07-2020.

Volume 54, Issue 3S · pp. s457–s463 · PUBLISHED 2020 · DOI: 10.5530/ijper.54.3s.144

View on IJPER original site ↗

ABSTRACT

The coronavirus disease 19 (COVID-19) is a pandemic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, COVID-19 has affected 210 countries and territories around the world. But there is no clinically approved antiviral drug or vaccine against COVID-19. Governments, private manufactures, academic institutions and non-profit organizations are working hard at a breakneck pace to develop a vaccine for COVID-19. However, vaccine development is very lengthy and expensive process, typically takes many years to produce a licensed vaccine. Because of the high failure rates and cost factors, developers generally follow a linear development sequence with multiple pauses for analysis of data. But in view of the COVID-19 pandemic, development steps need to be executed parallel before confirming the outcome of the previous step. In the current review, we summarize the process involved in the COVID-19 vaccine development and its challenges.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Sebastian, J., Ravi, M. D., & Kumar, T. P. (2020). COVID-19 Vaccine Development, Trials and Tribulations. Indian Journal of Pharmaceutical Education and Research, 54(3S), s457–s463. https://doi.org/10.5530/ijper.54.3s.144